hepcinat Lp

hepcinat Lp

Send Inquiry

We are a well acclaimed pharmaceutical company, engaged in supplying the best stock of Hepcinat LP. The medicine is specially formulated using an excellent combination of two anti- viral medications, viz Ledipasvir and Sofosbuvir. The Hepcinat Lp is widely used in the treatment of chronic hepatitis C virus (CHCV) infection genotype 1. It is basically a prescription medicine which contains Ledipasvir, a viral NS5A inhibitor and Sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase.

Key points:

  • A cure rate between 94% and 99%
  • Prevents multiplication of hepatitis C virus infection
  • It weakens the virus and inhibits its reproduction and replication

Hepatitis C is a viral infection that causes inflammation of the liver. Genotypes are used to identify particular strains of HCV which are based upon differences in particular regions of the viral genome. HARVONI (Gilead Sciences, Inc.) is a prescription medicine which contains a combination of Sofosbuvir and Ledipasvir in the dosages form of 90mg and 400 mg that is used for treatment of Chronic Hepatitis C (CHC) genotype 1 infection in adults. It is not recognized yet if HARVONI is safe and effective medicine for children under 18 years of age.
Genotype 1 HCV is the most common infection accounting for 70 to 75% of the entirely Hepatitis C infections in the UNITED STATES. Ledipasvir and Sofosbuvir are antiviral medications that help to prevent hepatitis C virus (HCV) cells from multiplying in your body.
The Indian generic of HARVONI to be manufactured by NATCO PHARMA LIMITED is available now in INDIA under the trade name HEPCINAT-LP. This drug also have similar effects as HARVONI in treating Chronic Hepatitis C (CHC) genotype 1 infection in adults. The recommended dosage of Hepcinat-LP is one tablet taken orally once daily with or without food.